These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 22185740

  • 41. No mucosal atrophy and reduced inflammatory cells: active-controlled trial with yearlong fluticasone furoate nasal spray.
    Fokkens WJ, Rinia B, van Drunen CM, Hellings PW, Hens G, Jansen A, Blom H, Wu W, Clements DS, Lee LA, Philpot EE.
    Am J Rhinol Allergy; 2012; 26(1):36-44. PubMed ID: 22391079
    [Abstract] [Full Text] [Related]

  • 42. Nasal nitric oxide concentration in suspected chronic rhinosinusitis.
    Bommarito L, Guida G, Heffler E, Badiu I, Nebiolo F, Usai A, De Stefani A, Rolla G.
    Ann Allergy Asthma Immunol; 2008 Oct; 101(4):358-62. PubMed ID: 18939722
    [Abstract] [Full Text] [Related]

  • 43. [The methodological aspects of nasal and exhaled nitric oxide levels in adult Japanese asthmatics].
    Tsuburai T, Tsurikisawa N, Ishii T, Higashi N, Higashi A, Morita S, Fukutomi Y, Tanimoto H, Sekiya K, Oshikata C, Ono E, Otomo M, Maeda Y, Ikehara K, Taniguchi M, Akiyama K.
    Arerugi; 2008 Aug; 57(8):1012-21. PubMed ID: 18781106
    [Abstract] [Full Text] [Related]

  • 44. Levocetirizine improves health-related quality of life and health status in persistent allergic rhinitis.
    Walter Canonica G, Bousquet J, Van Hammée G, Bachert C, Durham SR, Klimek L, Mullol J, Van Cauwenberge PB, XPERT Study Group.
    Respir Med; 2006 Oct; 100(10):1706-15. PubMed ID: 16723217
    [Abstract] [Full Text] [Related]

  • 45. [Effect of topical steroid on oral and nasal nitric oxide production in patients with allergic rhinitis].
    Gao Q, Zhang Y, Wang C, Zhao Y, Zhang L.
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Oct; 25(20):913-5, 919. PubMed ID: 22239049
    [Abstract] [Full Text] [Related]

  • 46. Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitis.
    Patel P, Philip G, Yang W, Call R, Horak F, LaForce C, Gilles L, Garrett GC, Dass SB, Knorr BA, Reiss TF.
    Ann Allergy Asthma Immunol; 2005 Dec; 95(6):551-7. PubMed ID: 16400895
    [Abstract] [Full Text] [Related]

  • 47. Comparative study of cetirizine and terfenadine versus placebo in the symptomatic management of seasonal allergic rhinitis.
    Lockey RF, Widlitz MD, Mitchell DQ, Lumry W, Dockhorn R, Woehler T, Grossman J.
    Ann Allergy Asthma Immunol; 1996 May; 76(5):448-54. PubMed ID: 8630719
    [Abstract] [Full Text] [Related]

  • 48. Effects of montelukast on quality of life in patients with persistent allergic rhinitis.
    Cingi C, Ozlugedik S.
    Otolaryngol Head Neck Surg; 2010 May; 142(5):654-8. PubMed ID: 20416451
    [Abstract] [Full Text] [Related]

  • 49. Rupatadine and levocetirizine for seasonal allergic rhinitis: a comparative study of efficacy and safety.
    Maiti R, Rahman J, Jaida J, Allala U, Palani A.
    Arch Otolaryngol Head Neck Surg; 2010 Aug; 136(8):796-800. PubMed ID: 20713756
    [Abstract] [Full Text] [Related]

  • 50. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study.
    Kuna P, Bachert C, Nowacki Z, van Cauwenberge P, Agache I, Fouquert L, Roger A, Sologuren A, Valiente R, Bilastine International Working Group.
    Clin Exp Allergy; 2009 Sep; 39(9):1338-47. PubMed ID: 19438584
    [Abstract] [Full Text] [Related]

  • 51. Cetirizine and pseudoephedrine retard, given alone or in combination, in patients with seasonal allergic rhinitis.
    Grosclaude M, Mees K, Pinelli ME, Lucas M, Van de Venne H.
    Rhinology; 1997 Jun; 35(2):67-73. PubMed ID: 9299654
    [Abstract] [Full Text] [Related]

  • 52. Nasal carbon dioxide for the symptomatic treatment of perennial allergic rhinitis.
    Casale TB, Korenblat PE, Meltzer EO, Yen K, Bhatnagar A.
    Ann Allergy Asthma Immunol; 2011 Oct; 107(4):364-70. PubMed ID: 21962098
    [Abstract] [Full Text] [Related]

  • 53. Clinical efficacy of halophilic lactic acid bacterium Tetragenococcus halophilus Th221 from soy sauce moromi for perennial allergic rhinitis.
    Nishimura I, Igarashi T, Enomoto T, Dake Y, Okuno Y, Obata A.
    Allergol Int; 2009 Jun; 58(2):179-85. PubMed ID: 19240374
    [Abstract] [Full Text] [Related]

  • 54. Randomized placebo-controlled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2-6 yr.
    Chen ST, Lu KH, Sun HL, Chang WT, Lue KH, Chou MC.
    Pediatr Allergy Immunol; 2006 Feb; 17(1):49-54. PubMed ID: 16426255
    [Abstract] [Full Text] [Related]

  • 55. Efficacy of mometasone furoate nasal spray for nasal symptoms, quality of life, rhinitis-disturbed sleep, and nasal nitric oxide in patients with perennial allergic rhinitis.
    Yamada T, Yamamoto H, Kubo S, Sakashita M, Tokunaga T, Susuki D, Narita N, Ogi K, Kanno M, Yamashita S, Terasawa Y, Kayano Y, Masada M, Fujieda S.
    Allergy Asthma Proc; 2012 Feb; 33(2):e9-16. PubMed ID: 22525384
    [Abstract] [Full Text] [Related]

  • 56. Nasal eosinophilia and serum soluble intercellular adhesion molecule 1 in patients with allergic rhinitis treated with montelukast alone or in combination with desloratadine or levocetirizine.
    Ciebiada M, Barylski M, Gorska Ciebiada M.
    Am J Rhinol Allergy; 2013 Feb; 27(2):e58-62. PubMed ID: 23562192
    [Abstract] [Full Text] [Related]

  • 57. Montelukast decreased exhaled nitric oxide in children with perennial allergic rhinitis.
    Hung CH, Hua YM, Hsu WT, Lai YS, Yang KD, Jong YJ, Chu YT.
    Pediatr Int; 2007 Jun; 49(3):322-7. PubMed ID: 17532829
    [Abstract] [Full Text] [Related]

  • 58. Double-blind study of cetirizine and loratadine versus placebo in patients with allergic rhinitis.
    Nunes C, Ladeira S.
    J Investig Allergol Clin Immunol; 2000 Jun; 10(1):20-3. PubMed ID: 10780795
    [Abstract] [Full Text] [Related]

  • 59. Anti-inflammatory activity and clinical efficacy of a 3-month levocetirizine therapy in mite-allergic children.
    Marcucci F, Sensi LG, Abate P, Allocca G, Ugolini E, Di Cara G, Incorvaia C.
    Inflamm Allergy Drug Targets; 2011 Feb; 10(1):32-8. PubMed ID: 21184653
    [Abstract] [Full Text] [Related]

  • 60. Nasal levels of nitric oxide as an outcome variable in allergic upper respiratory tract disease: Influence of atopy and hayfever on nNO.
    Moody A, Fergusson W, Wells A, Bartley J, Kolbe J.
    Am J Rhinol; 2006 Feb; 20(5):425-9. PubMed ID: 17063731
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.